老巫婆
发表于 2025-3-28 16:01:12
Poets, Princes and Fallen Figures of either falling asleep or sleeping through the night). While increased need for sleep and abnormal daytime sleepiness are frequent phenomena in older people, patients themselves rarely consider this a relevant problem. The present chapter focuses on insomnia, the most important and frequent sleep
sigmoid-colon
发表于 2025-3-28 22:27:53
Atrial Fibrillation group, suffer from it. In the United States alone, 2.2 million patients have AF, with an unknown number of undiagnosed cases (which may represent another two million patients), and this figure is expected to at least double by 2050. In Europe, the number of AF patients is estimated to be around six million.
外露
发表于 2025-3-28 23:38:51
http://reply.papertrans.cn/29/2832/283138/283138_43.png
extrovert
发表于 2025-3-29 04:30:24
http://reply.papertrans.cn/29/2832/283138/283138_44.png
吹牛大王
发表于 2025-3-29 10:46:26
assessment of drugs suitable for the aged. In view of the multimorbidity and polypharmacy situations experienced by elderly patients, this book takes into account the special needs and requirements shown by this group, thus serving as a timely reference for physicians who treat the elderly. .978-3-7091-0911-3978-3-7091-0912-0
是限制
发表于 2025-3-29 15:13:26
Book 2013itable for the aged. In view of the multimorbidity and polypharmacy situations experienced by elderly patients, this book takes into account the special needs and requirements shown by this group, thus serving as a timely reference for physicians who treat the elderly. .
蛙鸣声
发表于 2025-3-29 17:04:27
http://reply.papertrans.cn/29/2832/283138/283138_47.png
尊重
发表于 2025-3-29 20:38:06
http://reply.papertrans.cn/29/2832/283138/283138_48.png
Encephalitis
发表于 2025-3-30 01:28:30
http://reply.papertrans.cn/29/2832/283138/283138_49.png
PANEL
发表于 2025-3-30 06:52:50
2; Cowie et al. 1999). In the general population, about 1% of all people suffer from heart failure; in persons aged 85+, this figure rises to greater than 30% (Roger et al. 2011; data from Framingham, Fig. 3).